IHC Marker-WT-1 Test

The IHC marker-WT-1 test procedure analyses a preserved tissue section to detect WT-1 protein expression. WT-1 is a transcription factor, meaning it helps regulate gene activity, and is normally found in a limited set of tissues, such as the kidney, mesothelium (the thin membrane lining body cavities), and parts of the reproductive system.

The test evaluates three aspects of tissue staining:

• WT-1 protein expression: Only staining seen in the cell nucleus is considered a true positive result. Staining confined to the cytoplasm (the cell's outer region) is regarded as non-specific and is not counted as a positive finding.
• Staining pattern: The pathologist notes whether staining occurs in the nucleus or cytoplasm, as this distinction guides diagnosis.
• Staining intensity: Graded as weak (1+), moderate (2+), or strong (3+). Higher intensity often reflects stronger protein expression.

Since this test is performed on a tissue sample collected by your doctor, your preparation focuses on documentation rather than physical readiness.

Do You Need to Fast?

No fasting is required. This test is carried out on tissue obtained during a biopsy or surgical procedure, not on a blood sample. Follow any separate instructions your surgeon gives regarding the biopsy itself.

Practical Tips Before Your Test

Keep the following in mind before submitting your tissue sample:

• Bring a detailed clinical history, including your symptoms, previous test results, and family history, as this is required for the test
• Carry your doctor's referral letter, which should mention the biopsy site and relevant clinical background
• Bring any previous histopathology reports if you are submitting an existing paraffin block
• Include relevant imaging reports such as CT scans, MRIs, PET scans, or X-rays
• Ensure the tissue block is clearly labelled with your name, age, and identification details
• Inform your doctor about all medications you are currently taking

Step-by-Step Procedure

The IHC marker-WT-1 test procedure involves several laboratory steps after tissue collection:

1. Your doctor obtains a tissue sample through a needle biopsy, incisional biopsy, or surgical removal. No separate sample collection is needed for the IHC test itself.
2. The tissue is placed in formalin solution to preserve its structure, then embedded in a paraffin wax block.
3. A precision instrument called a microtome cuts very thin slices from the tissue block.
4. The sections undergo a process called heat-induced epitope retrieval (unmasking the proteins within the tissue) using a citrate buffer, followed by incubation with an anti-WT1 antibody.
5. The stained slides are reviewed under a microscope by a qualified pathologist, who records the staining location, pattern, and intensity.
6. The final report is prepared and shared with your treating doctor, typically within 7 days.

Factors That Can Affect Accuracy

Several factors can influence the quality and reliability of the staining result:

• Prolonged formalin fixation can cross-link proteins and reduce detection of specific markers
• Poorly preserved or necrotic (dead) tissue may produce inconsistent staining
• The specific antibody clone used (common clones include C-19, 6F-H2, and WT49) varies in sensitivity
• The antigen retrieval technique applied in the laboratory
• Quality of tissue handling between collection and processing

This test is a diagnostic tool for tumour classification, not a health screening marker. General wellness advice does not apply to this test. Your doctor will guide you on next steps based on the overall biopsy findings and clinical picture.